News & Alerts
-
Jul- 2023 -31 July
FDA Rejects Citius Bid to Replace Ontak With Lymphir
Recently, Citius Pharmaceuticals faced a significant setback when the U.S. Food and Drug Administration (FDA) rejected their application for Lymphir…
Read More » -
31 July
Takeda Faces Setback as Phase 3 Trial for Promising Lung Cancer Drug Exkivity Fails
In a major blow to Takeda Pharmaceutical Company, the highly anticipated targeted non-small cell lung drug Exkivity has suffered a…
Read More » -
31 July
Why Dr. Irene Kimura’s License Was Revoked Permanently
A Washington physician, Dr. Irene Kimura, has had her medical license permanently revoked by the Washington Department of Health after…
Read More » -
31 July
How a Nurse Killed 2 Patients With Lethal Doses Of Insulin
In a shocking and tragic turn of events, a registered nurse from Pennsylvania, Heather Pressdee, has been charged with murder…
Read More » -
31 July
Vabysmo Exceeds Expectations Surpass $1 Billion Sales Mark
In the world of pharmaceuticals, Roche’s eye drug Vabysmo has been gaining unstoppable “momentum,” according to Teresa Graham, the company’s…
Read More » -
31 July
Toxic Cough Syrups Kill 300 Infants Sparks Investigation By WHO
In a recent report, the World Health Organization (WHO) has revealed an alarming global threat posed by toxic cough syrups…
Read More » -
29 July
How I Discovered I Had Breast Cancer – Jane’s Diary
Today, my world shook to its core as I discovered something that I never thought would happen to me. It…
Read More » -
29 July
Empathetic Remarks By Doctors to Patients Can Reduce Pain – Study
Physicians’ displays of empathy towards their patients have been shown to reduce the sensation of pain, according to a recent…
Read More » -
28 July
Positive Outlook: AstraZeneca CEO Praises Interim Data from Lung Cancer Drug Trial
AstraZeneca’s Chief Executive, Pascal Soriot, expressed optimism about the interim data from a crucial lung cancer drug trial. The trial…
Read More » -
28 July
Bristol Myers Revise 2023 Outlook After Revenue Decline
Last year, Bristol Myers Squibb achieved a significant milestone by securing FDA approvals for three drugs, each with a peak…
Read More »